Luteolin alleviates neuroinflammation

25 May 2008

A study published in the May 19 issue of the Proceedings of the National Academy of Sciences found that the naturally-occurring compound luteolin could help alleviate brain inflammation.

Found in high concentrations in celery and green pepper, this flavanoid has been shown to reduce production of pro-inflammatory mediators in several different cell types stimulated with the commonly-used experimental toxin lipopolysaccharide. Because excessive production of pro-inflammatory cytokines by activated brain microglia can cause behavioral pathology and neurodegeneration, a team of US researchers sought to determine whether luteolin also regulates microglial cell production of a prototypic inflammatory cytokine, interleukin-6.

Led by Rodney Johnson, the University of Illinois scientists provided mice with drinking water supplemented with luteolin for 21 days and then injected them with LPS. Luteolin consumption reduced LPS-induced IL-6 in plasma four hours after injection and decreased the induction of IL-6 mRNA by LPS in the hippocampus but not in the cortex or cerebellum. "Taken together, these data suggest luteolin inhibits LPS-induced IL-6 production in the brain by inhibiting the JNK signaling pathway and activation of AP-1 in microglia. Thus, luteolin may be useful for mitigating neuroinflammation," wrote Dr Johnson.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK







Today's issue

Company Spotlight